SCHEMBL3842422

SCHEMBL3842422

O=C(O)CCCc1cc(O)ccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.54
LCK P06239 1/20 0.54
F13A1 P00488 3/20 0.48
POLB P06746 1/20 0.47
TYR P14679 2/20 0.47
HDAC3 O15379 1/20 0.47
MAPK1 P28482 1/20 0.47
ADRA1A P35348 1/20 0.47
HDAC4 P56524 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HDAC1 Q13547 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582394 0.94 F13A1 (0.56) EGFRLCKF13A1POLBTYR
SCHEMBL4148828 0.93 F13A1 (0.59) EGFRLCKF13A1TYRALDH1A1
SCHEMBL3840098 0.93 F13A1 (0.59) EGFRLCKF13A1TYRALDH1A1
SCHEMBL3838231 0.93 F13A1 (0.59) EGFRLCKF13A1TYRALDH1A1
SCHEMBL2381980 0.93 F13A1 (0.59) EGFRLCKF13A1TYRALDH1A1
SCHEMBL3835233 0.90 F13A1 (0.49) EGFRLCKF13A1POLBTYR
SCHEMBL8764373 0.89 TYR (0.63) POLBTYRTP53CYP3A4ALOX15
SCHEMBL490884 0.88 EGFR (0.57) EGFRLCKPOLBTYRALDH1A1
SCHEMBL7794268 0.87 EGFR (0.49) EGFRLCKTYRALDH1A1TP53
SCHEMBL8764494 0.85 TYR (0.59) F13A1POLBTYRTP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5449518-A Bleaching, decoloring skin L'OREAL (FR) 1995-09-12 US claimed
EP-0526302-B1 Depigmentation composition containing derivatives of (2,5-dihydroxyphenyl)-carboxylica OREAL (FR) 1995-03-01 EP claimed
US-8505730-B2 Compositions, kits and regimens for the treatment of skin, especially décolletage JR CHEM, LLC (US) 2013-08-13 US disclosed
US-20120312717-A1 COMPOSITIONS, KITS AND REGIMENS FOR THE TREATMENT OF SKIN, ESPECIALLY DECOLLETAGE JR CHEM, LLC (US) 2012-12-13 US disclosed
US-8273791-B2 Compositions, kits and regimens for the treatment of skin, especially décolletage JR CHEM, LLC (US) 2012-09-25 US disclosed
EP-2087880-A2 Compositions, kits and regimens for the treatment of skin, especially décolletage Jr Chem, LLC (US) 2009-08-12 EP disclosed
US-20090176876-A1 COMPOSITIONS, KITS AND REGIMENS FOR THE TREATMENT OF SKIN, ESPECIALLY DECOLLETAGE JR CHEM, LLC (US) 2009-07-09 US disclosed
US-6960347-B2 Composition based on N-cholesteryloxycarbonyl-4-para-aminophenol and hydroquinone or one of its derivatives L'OREAL (FR) 2005-11-01 US disclosed
US-20010036446-A1 Composition based on N-cholesteryloxycarbonyl-4-para-aminophenol and hydroquinone or one of its derivatives L'OREAL (FR) 2001-11-01 US disclosed
US-5667792-A CARBOXY DERIVATIVES OF HYDROQUINONE AS BLEACHES FOR SKIN L'OREAL (FR) 1997-09-16 US disclosed
US-5637756-A TREATMENT OF SKIN DISORDERS, BLEACHING OF PIGMENTED SPOTS, COSMETICS L'OREAL (FR) 1997-06-10 US disclosed
US-5587173-A Utilization of derivatives of 2,5 dihydroxyphenyl-carboxylic acid amides and their salts in preparation of a cosmetic or dermatological composition with a depigmenting action L'OREAL (FR) 1996-12-24 US disclosed
US-5585105-A Utilization of derivatives of 2,5-dihydroxyphenylcarboxylic acids, their homologs, and their salts in preparation of a cosmetic or dermatological composition with a depigmenting action L'OREAL (FR) 1996-12-17 US disclosed
EP-0509149-B1 Thermal dye sublimation transfer receiving element AGFA GEVAERT NV (BE) 1996-03-13 EP disclosed
US-5449518-A Bleaching, decoloring skin L'OREAL (FR) 1995-09-12 US disclosed
US-5284815-A Image-receiving layer containing an isocyanate-based polymer having a crosslinked and cured surface; dyeability; releasability from the dye donor element AGFA-GEVAERT, N.V. (BE) 1994-02-08 US disclosed
EP-0509149-A1 Thermal dye sublimation transfer receiving element AGFA-GEVAERT N.V. (BE) 1992-10-21 EP disclosed
US-4168980-A SILVER IMIDAZOLINE-2-THIONE EASTMAN KODAK COMPANY (US) 1979-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176876-A1 COMPOSITIONS, KITS AND REGIMENS FOR THE TREATMENT OF SKIN, ESPECIALLY DECOLLETAGE RARG, RARA, RXRG EGFR 1252/4885LCK 2747/4885F13A1 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.